Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02403271
Title A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications

lung non-small cell carcinoma

Her2-receptor negative breast cancer

Her2-receptor positive breast cancer

pancreatic adenocarcinoma

Therapies

Durvalumab + Ibrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.